Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MultiCorp International, Inc. Announces the Hiring of Healthcare Executive to Become New Chief Executive Officer
Mr. David Gustafson to Take Over as CEO of Company

MultiCorp International, Inc, (OTC PINK: MCIC) announced today that the company has hired David Gustafson as the new CEO of the company.

The company released the following statement, "MultiCorp International, Inc. is excited to announce that Mr. David Gustafson has taken over the helm of Chief Executive Officer of the company on an interim basis. The current CEO, Mr. Paul D. Lisenby, is taking a leave of absence due to medical reasons. There is no timetable for his return. In the meantime, we welcome Mr. Gustafson aboard as our CEO to spearhead the efforts of the company in the further development of the patented migraine medicine. Mr. Gustafson's 35 years of broad based, comprehensive, professional experience in the health care industry ranging from the operation of hospitals to medical groups, to integrated health delivery systems will benefit the company in developing and managing the 4-Arm Study the FDA is requiring for the migraine medicine, move the drug into further clinical trials, and to look for additional opportunities in the healthcare field for the company that can be capitalized upon to bring in additional revenue and profits. The Board of Directors also stated that they may possibly change the name of the company to further reflect the company's direction in the healthcare sector. The BOD also stated there will be no changes to the share structure of the company at this time."

About MultiCorp International, Inc.

MultiCorp International, Inc is committed itself to the further development of the patented migraine medicine the company owns a significant percentage of. The company has received information from the U.S. Food and Drug Administration that provides the company with a clear path to further the development of the drug to bring to market. The company is currently looking to partner with a pharmaceutical company that can assist the company in bringing the migraine medicine to market. For further information please contact them at info@multicorpinternational.com

About Mr. David Gustafson

David Gustafson is an executive with over 35 years of broad based, comprehensive, professional experience in the health care industry ranging from the operation of hospitals to medical groups, to integrated health delivery systems. Hospitals he managed have ranged in size from 49 to over 300 beds. His managed care experience ranges from design and implementation of a new managed care psychiatric treatment product for a major health plan, to launch of hospital based IPAs and a specialty IPA, to providing executive leadership for a hospital operating in a very tightly structured integrated healthcare delivery system, successful start-up of an ACO, and more recently, managing two IPAs serving over 42,000 members in the Inland Empire of Southern California.

In playing out the Senior Executive's external role he has served in a variety of community organizations such as the United Way, Chamber of Commerce, and service clubs. A frequent public speaker he has served on the adjunct faculty of Concordia College, Moorhead Minnesota, and has lectured at Pepperdine University, before a variety of clubs and organizations, and at hospital association seminars.

David holds a B.A. Degree in Business from Moorhead State University in Minnesota, and a Master's Degree in Hospital Administration from the University of Minnesota, a program for which he has served as a preceptor and mentor.

Forward-Looking Statements

This press release may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products and services that we may not produce today and that meet defined specifications. When used in this press release, the words "plan," "expect," "believe," and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets.

 Top of page